Adding temozolomide to radiation therapy improves survival in adult patients with slow-growing brain tumor, trial finds

Both radiation and temozolomide, a generic chemotherapy treatment in pill form, have meaningful single-modality anti-tumor activity against slow-growing, low-grade gliomas. The randomized phase 3 trial E3F05 by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) tested whether combined therapy using temozolomide alongside radiation therapy is more effective than radiation therapy alone in these patients.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup